Showing results (2091-2100 of 2,629) with videos related to
Sort By:
Pageof 263
Alimentary Pharmacology & Therapeutics|April 23, 2002
Conditional loss of TGF-beta signalling leads to increased susceptibility to gastrointestinal carcinogenesis in miceK-B Hahm, K M Lee, Y B Kim, et al.Nature|October 4, 2008
Nanoscale magnetic sensing with an individual electronic spin in diamondJ R Maze, P L Stanwix, J S Hodges, et al.Blood|January 17, 2009
Expression of sprouty2 inhibits B-cell proliferation and is epigenetically silenced in mouse and human B-cell lymphomasMatthew J Frank, David W Dawson, Steven J Bensinger, et al.International Journal of Clinical Oncology|May 23, 2002
Phase II study of docetaxel and cisplatin combination chemotherapy in metastatic or unresectable localized non-small-cell lung cancerYeul H Kim, Jun S Kim, Young H Choi, et al.American Journal of Surgery|October 5, 2010
The effect of neoadjuvant chemoradiation therapy on the prognostic value of lymph nodes after rectal cancer surgeryCoen L Klos, Paul C Shellito, David W Rattner, et al.Bone Marrow Transplantation|April 26, 2016
Association of socioeconomic status with autologous hematopoietic cell transplantation outcomes for lymphomaS Hong, L Rybicki, D M Abounader, et al.Theranostics|May 4, 2018
Safety of panitumumab-IRDye800CW and cetuximab-IRDye800CW for fluorescence-guided surgical navigation in head and neck cancersRebecca W Gao, Nutte Teraphongphom, Esther de Boer, et al.Journal of Neurosurgery. Case Lessons|March 7, 2023
Vascular steal and associated intratumoral aneurysms in highly vascular brain tumors: illustrative caseChristopher S Hong, Neelan J Marianayagam, Saul F Morales-Valero, et al.Molecular Cancer Therapeutics|December 15, 2017
Phase I Dose-Escalation Study of Anti-CTLA-4 Antibody Ipilimumab and Lenalidomide in Patients with Advanced CancersDivya Sakamuri, Isabella C Glitza, Sonia L Betancourt Cuellar, et al.Plos One|March 4, 2014
FBXW7 mutations in patients with advanced cancers: clinical and molecular characteristics and outcomes with mTOR inhibitorsDenis L Jardim, Jennifer J Wheler, Kenneth Hess, et al.Pageof 263